Ticker > Company >

Thyrocare Tech. share price

Thyrocare Technologies Ltd.

NSE: THYROCARE BSE: 539871 SECTOR: Hospital & Healthcare Services  141k   564   69

1023.40
+1.25 (0.12%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 1028.9

Today's Low

₹ 971.05

52 Week High

₹ 1072.45

52 Week Low

₹ 605.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

5423.45 Cr.

Enterprise Value

5409.12 Cr.

No. of Shares

5.3 Cr.

P/E

56.62

P/B

10.1

Face Value

₹ 10

Div. Yield

2.05 %

Book Value (TTM)

₹  101.35

CASH

34.1 Cr.

DEBT

19.77 Cr.

Promoter Holding

71.06 %

EPS (TTM)

₹  18.07

Sales Growth

7.72%

ROE

13.87 %

ROCE

19.55%

Profit Growth

24.87 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Thyrocare Technologies Ltd.

Aarogyam WHATERS

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year7.72%
3 Year3.38%
5 Year7.19%

Profit Growth

1 Year21.96%
3 Year-15.52%
5 Year-5.63%

ROE%

1 Year13.87%
3 Year18.86%
5 Year21.02%

ROCE %

1 Year19.55%
3 Year26.52%
5 Year29.21%

Debt/Equity

0.0388

Price to Cash Flow

34.95

Interest Cover Ratio

21.127

CFO/PAT (5 Yr. Avg.)

1.31098591549296

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 71.06 100.00
Dec 2024 71.06 100.00
Sep 2024 71.11 100.00
Jun 2024 71.11 100.00
Mar 2024 71.11 100.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 26.5181276724352% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 21.127.
  • The Company has been maintaining an effective average operating margins of 33.6653455371464% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 1.07560000000001 days.
  • Company has a healthy liquidity position with current ratio of 3.2339.
  • The company has a good cash flow management; CFO/PAT stands at 1.31098591549296.

 Limitations

  • The company has shown a poor profit growth of -15.9401513416487% for the Past 3 years.
  • The company has shown a poor revenue growth of 3.38096739615257% for the Past 3 years.
  • The company is trading at a high PE of 56.62.
  • Promoter pledging is high as 100%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 141.23 143.63 163.05 152.55 173.87
Total Expenditure 107.64 101.28 114.26 112.3 118.23
Operating Profit 33.59 42.35 48.79 40.25 55.64
Other Income 2.81 3.17 2.12 3.51 4.54
Interest 0.94 0.93 0.63 0.48 0.6
Depreciation 10.41 9.45 9.94 15.34 11.78
Exceptional Items 0 0 0 0 0
Profit Before Tax 25.05 35.14 40.34 27.94 47.8
Tax 5.82 9.99 10.75 8.84 25.85
Profit After Tax 19.23 25.15 29.59 19.1 21.95
Adjusted EPS (Rs) 3.63 4.75 5.59 3.6 4.14

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 401.06 474.27 561.53 486.46 524.02
Total Expenditure 233.29 303.53 330 372.16 389
Operating Profit 167.77 170.74 231.53 114.3 135.02
Other Income 9.42 12.28 7.4 5.39 7.18
Interest 1.32 0.66 3.08 4.54 4.88
Depreciation 19.54 21.08 28.47 34.08 39.1
Exceptional Items -44.33 0 0 0 0
Profit Before Tax 112 161.28 207.38 81.07 98.22
Tax 32.68 41.51 55.33 24.1 27.08
Net Profit 79.44 118.36 152.01 58.51 71.36
Adjusted EPS (Rs.) 15.01 22.65 28.74 10.76 13.44

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 52.84 52.87 52.9 52.93 52.95
Total Reserves 325.39 392.59 467.8 468.11 460.86
Borrowings 0 0 0 0 10.91
Other N/C liabilities 1.77 4.78 0.43 138.04 -4.58
Current liabilities 50.75 62.69 211.03 145.88 75.96
Total Liabilities 430.75 512.93 732.16 804.96 596.1
Assets
Net Block 110.39 118.03 148.31 155.63 158.29
Capital WIP 3.87 8.28 2.15 0.82 0.76
Intangible WIP 0 0 0 0 0
Investments 170.34 170.34 170.34 172.75 176.2
Loans & Advances 27.67 29.06 23.77 163.54 12.91
Other N/C Assets 5.21 4.72 5.83 3.02 2.29
Current Assets 113.27 182.5 381.76 309.2 245.65
Total Assets 430.75 512.93 732.16 804.96 596.1
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 156.33 161.28 207.38 81.07 98.22
Adjustment 15.76 14.16 38.05 63.4 63.77
Changes in Assets & Liabilities 8.49 -20.78 -83.43 4.25 22.19
Tax Paid -44.25 -43.59 -56.32 -28.7 -28.99
Operating Cash Flow 136.33 111.07 105.68 120.02 155.19
Investing Cash Flow 26.84 -53.09 -12.32 -31.65 -80.29
Financing Cash Flow -162.65 -57.81 -86.91 -87.5 -83.71
Net Cash Flow 0.52 0.17 6.45 0.87 -8.81

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 71.11 71.11 71.11 71.06 71.06
docon technologies privat... 71.11 71.11 71.11 71.06 71.06
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 28.89 28.89 28.89 28.94 28.94
dsp india t.i.g.e.r. fund... - - - - 1.22
icici prudential pharma h... - 4.15 3.37 2.75 2.65
llp 0.13 0.14 0.07 0.09 0.08
nippon life india trustee... 7.30 6.69 7.06 7.05 7.05
quant mutual fund - quant... - 1.39 1.80 2.08 1.96
theleme india master fund... 1.41 1.36 - - -
icici prudential india op... 4.98 - - - -

Annual Reports

Title Action
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY ACTION
No Credit reports exist for this company.Report us
TYPE AGENCY ACTION
Research HDFC Securities
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER ACTION
Concall Q4FY24
Concall Q4FY23
Concall Q4FY19
Concall Q3FY24
Concall Q3FY21
Concall Q2FY24
Concall Q1FY25
TYPE QUARTER ACTION
Presentation Q4FY25
Presentation Q4FY24
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY25
Presentation Q2FY25
Presentation Q2FY23
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY25
Presentation Q1FY23
Presentation Q1FY22
Presentation Q1FY21

Company News

Thyrocare Tech. Stock Price Analysis and Quick Research Report. Is Thyrocare Tech. an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Thyrocare Tech. and its performance over the period of time. Thyrocare Tech. stock price today is Rs 1021.5.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Thyrocare Tech. cash from the operating activity was Rs 155.19 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Thyrocare Tech. has a Debt to Equity ratio of 0.0388 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Thyrocare Tech. , the EPS growth was 24.8251 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Thyrocare Tech. has OPM of 25.7661921300714 % which is a good sign for profitability.
     
  • ROE: Thyrocare Tech. have a average ROE of 13.8669 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Thyrocare Tech. is Rs 1021.5. One can use valuation calculators of ticker to know if Thyrocare Tech. share price is undervalued or overvalued.
Last Updated on:
Brief about Thyrocare Tech.
X